Compare AUTL & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | CCIX |
|---|---|---|
| Founded | 2014 | 2023 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 390.8M |
| IPO Year | 2025 | N/A |
| Metric | AUTL | CCIX |
|---|---|---|
| Price | $1.59 | $10.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 11.9K |
| Earning Date | 05-07-2026 | 11-07-2013 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $84.74 | N/A |
| Revenue Next Year | $65.76 | N/A |
| P/E Ratio | ★ N/A | $45.59 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.15 | $10.46 |
| 52 Week High | $2.70 | $11.66 |
| Indicator | AUTL | CCIX |
|---|---|---|
| Relative Strength Index (RSI) | 59.85 | 52.12 |
| Support Level | $1.22 | $10.55 |
| Resistance Level | $1.69 | $10.83 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 74.03 | 43.75 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Churchill Capital Corp IX is a blank check company.